Enzo Biochem Inc (ENZ) — Capital Reinvestment Ratio

Latest as of July 2021: 14.50x

Enzo Biochem Inc (ENZ) has a Capital Reinvestment Ratio of 14.50x as of July 2021, meaning it reinvests 15% of its operating cash flow ($108.00K) in capital expenditures ($1.57 Million). See how much free cash does Enzo Biochem Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

14.50x
Capex / Operating Cash Flow

Operating Cash Flow

$108.00K
USD

Capital Expenditures

$1.57 Million
USD

Data as of

Jul 2021
Most recent filing

Enzo Biochem Inc Capital Reinvestment Ratio (1992–2021)

This chart tracks Enzo Biochem Inc's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Enzo Biochem Inc (1992–2021)

Year-by-year Capital Reinvestment Ratio for Enzo Biochem Inc from 1992 to 2021. For live market cap and broader valuation context, see ENZ stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 11.46x $387.00K $4.44 Million ▲ +577.9%
2019 1.69x $4.81 Million $8.13 Million ▲ +5771.0%
2016 0.03x $53.13 Million $1.53 Million ▼ -71.0%
2005 0.10x $12.83 Million $1.28 Million ▲ +26.0%
2003 0.08x $12.12 Million $956.70K ▲ +21.6%
2002 0.06x $9.56 Million $620.40K ▼ -48.8%
2001 0.13x $8.00 Million $1.01 Million ▼ -20.9%
2000 0.16x $4.93 Million $790.50K ▲ +61.8%
1999 0.10x $11.10 Million $1.10 Million ▲ +37.1%
1998 0.07x $8.30 Million $600.00K ▼ -20.5%
1997 0.09x $7.70 Million $700.00K ▼ -20.8%
1996 0.11x $6.10 Million $700.00K ▲ +4.4%
1995 0.11x $9.10 Million $1.00 Million ▼ -90.2%
1993 1.13x $800.00K $900.00K ▲ +31.3%
1992 0.86x $2.10 Million $1.80 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow